Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.60% | 1.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.60% | 1.95% | |||
| Cost of Revenue | 0.02% | -3.26% | |||
| Gross Profit | 4.95% | 2.37% | |||
| SG&A Expenses | 0.99% | -7.77% | |||
| Depreciation & Amortization | 9.41% | -45.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.39% | -9.55% | |||
| Operating Income | -1.69% | 9,496.81% | |||
| Income Before Tax | -232.69% | 141.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -232.69% | 141.34% | |||
| Earnings from Discontinued Operations | 98.39% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -80.00% | -75.00% | |||
| Net Income | 94.71% | -1,409.69% | |||
| EBIT | -1.69% | 9,496.81% | |||
| EBITDA | -1.27% | 232.97% | |||
| EPS Basic | 94.60% | -1,403.68% | |||
| Normalized Basic EPS | -10.26% | 141.37% | |||
| EPS Diluted | 94.42% | -1,355.71% | |||
| Normalized Diluted EPS | -7.19% | 140.00% | |||
| Average Basic Shares Outstanding | -2.01% | 0.39% | |||
| Average Diluted Shares Outstanding | -5.23% | 3.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||